A cohort analysis to identify eligible patients for intraoperative radiotherapy (IORT) of early breast cancer

Radiation Oncology

Volumn 9, Issue 1, 2014, Pages

  Sperk, Elena ^a   Astor, Daniela ^a   Keller, Anke ^a   Welzel, Grit ^a   Gerhardt, Axel ^a   Tuschy, Benjamin ^a   Sütterlin, Marc ^a   Wenz, Frederik ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

APBI; Boost; Breast cancer; Eligibility; Intraoperative radiotherapy; IORT; Suitable patients

Indexed keywords

HORMONE RECEPTOR;

ARTICLE; BREAST CARCINOMA; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER STAGING; COHORT ANALYSIS; EXTERNAL BEAM RADIOTHERAPY; HISTOPATHOLOGY; HUMAN; INTRAOPERATIVE RADIOTHERAPY; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; RISK FACTOR; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CONTROLLED STUDY; FEMALE; FOLLOW UP; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PATIENT SELECTION; PEROPERATIVE CARE; PROGNOSIS; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SEGMENTAL MASTECTOMY; SURVIVAL RATE;

AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAOPERATIVE CARE; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; PROGNOSIS; RADIOTHERAPY DOSAGE; SURVIVAL RATE;

EID: 84904074107     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-9-154     Document Type: Article

References (26)

1. Shah C, Badiyan S, Ben Wilkinson J, Vicini F, Beitsch P, Keisch M, Arthur D, Lyden M. Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American society of breast surgeons MammoSite(®) breast brachytherapy registry trial. Ann Surg Oncol 2013, 20(10):3279-3285.
2. Polgár C, Fodor J, Major T, Sulyok Z, Kásler M. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol 2013, 108(2):197-202.
3. Pashtan IM, Recht A, Ancukiewicz M, Brachtel E, Abi-Raad RF, D'Alessandro HA, Levy A, Wo JY, Hirsch AE, Kachnic LA, Goldberg S, Specht M, Gadd M, Smith BL, Powell SN, Taghian AG. External beam accelerated partial-breast irradiation using 32 gy in 8 twice-daily fractions: 5-year results of a prospective study. Int J Radiat Oncol Biol Phys 2012, 84(3):e271-e277.
4. Lemanski C, Azria D, Gourgou-Bourgade S, Ailleres N, Pastant A, Rouanet P, Fenoglietto P, Dubois JB, Gutowski M. Electrons for intraoperative radiotherapy in selected breast-cancer patients: late results of the Montpellier phase II trial. Radiat Oncol 2013, 8(1):191.
5. Veronesi U, Orecchia R, Maisonneuve P, Viale G, Rotmensz N, Sangalli C, Luini A, Veronesi P, Galimberti V, Zurrida S, Leonardi MC, Lazzari R, Cattani F, Gentilini O, Intra M, Caldarella P, Ballardini B. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol 2013, 14(13):1269-1277.
6. Vaidya JS, Joseph DJ, Tobias JS, Bulsara M, Wenz F, Saunders C, Alvarado M, Flyger HL, Massarut S, Eiermann W, Keshtgar M, Dewar J, Kraus-Tiefenbacher U, Sütterlin M, Esserman L, Holtveg HM, Roncadin M, Pigorsch S, Metaxas M, Falzon M, Matthews A, Corica T, Williams NR, Baum M. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 2010, 376(9735):91-102. Erratum in: Lancet. 2010, 376(9735):90.
7. Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Keshtgar M, Flyger HL, Massarut S, Alvarado M, Saunders C, Eiermann W, Metaxas M, Sperk E, Sütterlin M, Brown D, Esserman L, Roncadin M, Thompson A, Dewar JA, Holtveg HM, Pigorsch S, Falzon M, Harris E, Matthews A, Brew-Graves C, Potyka I, Corica T, Williams NR, Baum M, . on behalf of the TARGIT trialists' group Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet 2014, 383(9917):603-613. Erratum in: Lancet 2014, 383(9917):602, on behalf of the TARGIT trialists' group.
8. Sperk E, Welzel G, Keller A, Kraus-Tiefenbacher U, Gerhardt A, Sütterlin M, Wenz F. Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A. Breast Cancer Res Treat 2012, 135(1):253-260.
9. Neumaier C, Elena S, Grit W, Yasser AM, Uta KT, Anke K, Axel G, Marc S, Frederik W. TARGIT-E(lderly)-prospective phase II study of intraoperative radiotherapy (IORT) in elderly patients with small breast cancer. BMC Cancer 2012, 12:171.
10. S3 (2012) interdisziplinäre S3-leitlinie für die diagnostik, therapie und nachsorge des mammakarzinoms, langversion 3.0, aktualisierung 2012, AWMF-Register-Nummer: 032 - 045OL http://www.awmf.org/uploads/tx_szleitlinien/032-045OL_k_S3__Brustkrebs_Mammakarzinom_Diagnostik_Therapie_Nachsorge_2012-07.pdf.
11. Sedlmayer F, Sautter-Bihl ML, Budach W, Dunst J, Fastner G, Feyer P, Fietkau R, Haase W, Harms W, Souchon R, Wenz F, Sauer R, . Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer. Strahlenther Onkol 2013, 189(10):825-833. Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO).
12. Polgár C, Van Limbergen E, Pötter R, Kovács G, Polo A, Lyczek J, Hildebrandt G, Niehoff P, Guinot JL, Guedea F, Johansson B, Ott OJ, Major T, Strnad V, . GEC-ESTRO breast cancer working group Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the groupe européen de curie thérapie-european society for therapeutic radiology and oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol 2010, 94(3):264-273. GEC-ESTRO breast cancer working group.
13. Smith BD, Arthur DW, Buchholz TA, Haffty BG, Hahn CA, Hardenbergh PH, Julian TB, Marks LB, Todor DA, Vicini FA, Whelan TJ, White J, Wo JY, Harris JR. Accelerated partial breast irradiation consensus statement from the American society for radiation oncology (ASTRO). Int J Radiat Oncol Biol Phys 2009, 74(4):987-1001.
14. Kraus-Tiefenbacher U, Steil V, Bauer L, Melchert F, Wenz F. A novel device for intraoperative radiotherapy (IORT). Onkologie 2003, 26:596-598.
15. Tuschy B, Berlit S, Nasterlack C, Tomé K, Blank E, Wenz F, Sütterlin M. Intraoperative radiotherapy of early breast cancer using low-kilovoltage x-rays - reasons for omission of planned intraoperative irradiation. Breast J 2013, 19(3):325-328.
16. Leonardi MC, Maisonneuve P, Mastropasqua MG, Morra A, Lazzari R, Dell'Acqua V, Ferrari A, Rotmensz N, Sangalli C, Luini A, Veronesi U, Orecchia R. Accelerated partial breast irradiation with intraoperative electrons: using GEC-ESTRO recommendations as guidance for patient selection. Radiother Oncol 2013, 106(1):21-27.
17. Leonardi MC, Maisonneuve P, Mastropasqua MG, Morra A, Lazzari R, Rotmensz N, Sangalli C, Luini A, Veronesi U, Orecchia R. How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? a retrospective analysis of patients treated at the European institute of oncology. Int J Radiat Oncol Biol Phys 2012, 83(3):806-813.
18. Tuschy B, Berlit S, Romero S, Sperk E, Wenz F, Kehl S, Sütterlin M. Clinical aspects of intraoperative radiotherapy in early breast cancer: short-term complications after IORT in women treated with low energy x-rays. Radiat Oncol 2013, 8:95.
19. Kraus-Tiefenbacher U, Bauer L, Kehrer T, Hermann B, Melchert F, Wenz F. Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer - acute toxicity. Onkologie 2006, 29(3):77-82.
20. Wenz F, Welzel G, Keller A, Blank E, Vorodi F, Herskind C, Tomé O, Sütterlin M, Kraus-Tiefenbacher U. Early initiation of external beam radiotherapy (EBRT) may increase the risk of long-term toxicity in patients undergoing intraoperative radiotherapy (IORT) as a boost for breast cancer. Breast 2008, 17(6):617-622.
21. Blank E, Kraus-Tiefenbacher U, Welzel G, Keller A, Bohrer M, Sütterlin M, Wenz F. Single-center long-term follow-up after intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage x-rays. Ann Surg Oncol 2010, 17(Suppl 3):352-358.
22. Welzel G, Boch A, Sperk E, Hofmann F, Kraus-Tiefenbacher U, Gerhardt A, Suetterlin M, Wenz F. Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A. Radiat Oncol 2013, 8(1):9.
23. Welzel G, Hofmann F, Blank E, Kraus-Tiefenbacher U, Hermann B, Sütterlin M, Wenz F. Health-related quality of life after breast-conserving surgery and intraoperative radiotherapy for breast cancer using low-kilovoltage X-rays. Ann Surg Oncol 2010, 17(Suppl 3):359-367.
24. Aziz MH, Schneider F, Clausen S, Blank E, Herskind C, Afzal M, Wenz F. Can the risk of secondary cancer induction after breast conserving therapy be reduced using intraoperative radiotherapy (IORT) with low-energy x-rays?. Radiat Oncol 2011, 6:174.
25. Alvarado MD, Mohan AJ, Esserman LJ, Park CC, Harrison BL, Howe RJ, Thorsen C, Ozanne EM. Cost-effectiveness analysis of intraoperative radiation therapy for early-stage breast cancer. Ann Surg Oncol 2013, 20(9):2873-2880.
26. Blank E, Willich N, Fietkau R, Popp W, Schaller-Steiner J, Sack H, Wenz F. Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients: the DEGRO-QUIRO trial. Strahlenther Onkol 2012, 188(2):113-119.